Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Conavi Medical Corp. (CNVIF : OTC)

• Company Description    Conavi Medical Corp. is focused on designing, manufacturing and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. Its patented Novasight Hybrid(TM) System is the first system to combine both intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in TORONTO. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.13 Daily Weekly Monthly 20 Day Moving Average: 35,228 shares Shares Outstanding: 103.42 (millions) Market Capitalization: $13.31 (millions) Beta: 0.54 52 Week High: $0.56 52 Week Low: $0.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.60% -3.16% 12 Week -33.38% -34.80% Year To Date -61.06% -65.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 293 Lesmill Road - TORONTO,A6 M3B 2V1 CAN ph: 416-548-7522 fax: - stephen.kilmer@conavi.com http://www.conavi.com/novasight

• General Corporate Information    Officers Thomas Looby - Chief Executive Officer Sumeet Dham - Vice President; Research & Development John Lefavour - Vice President; Operations Mark Quick - Chief Financial Officer Julie Dunham - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 205953102 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/26 Next Expected EPS Date: 01/04/27 Share - Related Items Shares Outstanding: 103.42 Most Recent Split Date: 10.00 (0.04:1) Beta: 0.54 Market Capitalization: $13.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 01/04/27

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 19.07 EPS Growth vs. Year Ago Period: -100.00% vs. Previous Quarter: -100.00% Sales Growth vs. Year Ago Period: 291.30% vs. Previous Quarter: 89.47% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - -217.39 03/31/26 - -132.05 12/31/25 - -138.79 Current Ratio 06/30/26 - - 03/31/26 - 1.40 12/31/25 - 0.60 Quick Ratio 06/30/26 - - 03/31/26 - 1.39 12/31/25 - 0.60 Operating Margin 06/30/26 - -2,739.40 03/31/26 - -2,293.26 12/31/25 - -2,283.10 Net Margin 06/30/26 - -2,739.40 03/31/26 - -2,293.26 12/31/25 - -2,283.10 Pre-Tax Margin 06/30/26 - - 03/31/26 - -2,286.70 12/31/25 - -2,275.64 Book Value 06/30/26 - - 03/31/26 - -0.10 12/31/25 - -0.19 Inventory Turnover 06/30/26 - - 03/31/26 - 0.21 12/31/25 - -0.31 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©